Cell and Gene Therapy Catapult - Catapult Therapy TCR's Unit Acquisition

Cell and Gene Therapy Catapult - Catapult Therapy TCR raised a round of funding on June 20, 2017. Investors include Cell Medica.

Cell and Gene Therapy Catapult aims to advance the growth of the UK cell and gene therapy industry by bridging the gap between scientific research and full-scale commercialization. CGT Catapult offers…

Articles about Cell and Gene Therapy Catapult - Catapult Therapy TCR's Unit Acquisition: